Neurologic Disability | List of Frontiers open access articles

Brief Research Report

Published on 04 May 2021

The Time Burden of Specialty Clinic Visits in Persons With Neurologic Disease: A Case for Universal Telemedicine Coverage

in Neurorehabilitation

Daniel L. Solomon
Benjamin Dirlikov
Kazuko L. Shem
Christopher S. Elliott

Frontiers in Neurology

doi 10.3389/fneur.2021.559024

3,870 views
11 citations

Original Research

Published on 24 Jan 2023

Therapeutic potential of blocking GAPDH nitrosylation with CGP3466b in experimental autoimmune encephalomyelitis

in Multiple Sclerosis and Neuroimmunology

Wesley H. Godfrey
Soonmyung Hwang
Kaho Cho
Shruthi Shanmukha
Payam Gharibani
Efrat Abramson
Michael Davin Kornberg

Frontiers in Neurology

doi 10.3389/fneur.2022.979659

4,149 views
9 citations

Original Research

Published on 06 Jan 2017

Cerebrospinal Fluid in a Small Cohort of Patients with Multiple Sclerosis Was Generally Free of Microbial DNA

in Microbiome in Health and Disease

Juan Jovel
Sandra O'keefe
Jordan Patterson
Michael Bording-Jorgensen
Weiwei Wang
Andrew L. Mason
Kenneth G. Warren
Gane Ka-Shu Wong

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2016.00198

5,616 views
12 citations

Original Research

Published on 11 Apr 2022

CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome

in Viral Immunology

Mar Guasp
Guillermo Muñoz-Sánchez
Eugenia Martínez-Hernández
Daniel Santana
Álvaro Carbayo
Laura Naranjo
Uma Bolós
Mario Framil
Albert Saiz
Mircea Balasa

Frontiers in Immunology

doi 10.3389/fimmu.2022.866153

18,338 views
96 citations

Original Research

Published on 12 May 2023

Genetic and clinical features of pediatric-onset hereditary spastic paraplegia: a single-center study in Japan

in Pediatric Neurology

Azusa Ikeda
Tatsuro Kumaki
Yu Tsuyusaki
Megumi Tsuji
Yumi Enomoto
Atsushi Fujita
Hirotomo Saitsu
Naomichi Matsumoto
Kenji Kurosawa
Tomohide Goto

Frontiers in Neurology

doi 10.3389/fneur.2023.1085228

5,230 views
4 citations

Study Protocol

Published on 20 Sep 2019

Protocol for AREST: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation—A Randomized Controlled Trial of Early Anticoagulation After Acute Ischemic Stroke in Atrial Fibrillation

in Stroke

David Z. Rose
John N. Meriwether
Michael G. Fradley
Swetha Renati
Ryan C. Martin
Thomas Kasprowicz
Aarti Patel
Maxim Mokin
Ryan Murtagh
Kevin Kip

Frontiers in Neurology

doi 10.3389/fneur.2019.00975

11,803 views
8 citations

Articles

The Time Burden of Specialty Clinic Visits in Persons With Neurologic Disease: A Case for Universal Telemedicine Coverage

Therapeutic potential of blocking GAPDH nitrosylation with CGP3466b in experimental autoimmune encephalomyelitis

Cerebrospinal Fluid in a Small Cohort of Patients with Multiple Sclerosis Was Generally Free of Microbial DNA

CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome

Genetic and clinical features of pediatric-onset hereditary spastic paraplegia: a single-center study in Japan

Protocol for AREST: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation—A Randomized Controlled Trial of Early Anticoagulation After Acute Ischemic Stroke in Atrial Fibrillation